Temperature-controlled supply chain solutions firm Cryoport has partnered with VGCI, a subsidiary of GeneOne Life Science, to support the development of cell and gene therapies and mRNA-based treatments. Under terms of the deal, Cryoport will provide biostorage and bioservices for plasmid DNA products manufactured at VGXI’s facilities in the Woodlands, Texas, and its headquarters and manufacturing location, also in Texas.